BL-8040 Addition to Consolidation Therapy in AML Patients

NCT02502968 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

194

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: BL-8040
DRUG: Placebo (for BL-8040)

Sponsor

Dr. Petra Tschanter

Collaborators

[object Object]